HIV Envelope Protein gp160
"HIV Envelope Protein gp160" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An envelope protein of the human immunodeficiency virus that is encoded by the HIV env gene. It has a molecular weight of 160,000 kDa and contains numerous glycosylation sites. It serves as a precursor for both the HIV ENVELOPE PROTEIN GP120 and the HIV ENVELOPE PROTEIN GP41.
| Descriptor ID |
D019302
|
| MeSH Number(s) |
D12.776.964.775.325.164.374 D12.776.964.775.562.500.750 D12.776.964.970.880.325.164.374
|
| Concept/Terms |
HIV Envelope Protein gp160- HIV Envelope Protein gp160
- Envelope Glycoprotein gp160, HIV
- HTLV-III gp160
- HTLV III gp160
- gp160, HTLV-III
- gp160(HIV)
- HIV Envelope Glycoprotein gp160
- env Protein gp160, HIV
- gp160 Envelope Glycoprotein, HIV
|
Below are MeSH descriptors whose meaning is more general than "HIV Envelope Protein gp160".
Below are MeSH descriptors whose meaning is more specific than "HIV Envelope Protein gp160".
This graph shows the total number of publications written about "HIV Envelope Protein gp160" by people in this website by year, and whether "HIV Envelope Protein gp160" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 1 | 2 |
| 2001 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "HIV Envelope Protein gp160" by people in Profiles.
-
Engineered Bispecific Antibodies with Exquisite HIV-1-Neutralizing Activity. Cell. 2016 Jun 16; 165(7):1621-1631.
-
Redesigned HIV antibodies exhibit enhanced neutralizing potency and breadth. J Clin Invest. 2015 Jun; 125(6):2523-31.
-
Th cell-independent immune responses to chimeric hemagglutinin/simian human immunodeficiency virus-like particles vaccine. J Immunol. 2004 Aug 01; 173(3):1951-8.
-
Flow cytometric analysis of macaque whole blood for antigen-specific intracellular cytokine production by T lymphocytes. J Med Primatol. 2003 Feb; 32(1):23-30.
-
Safety and immunogenicity of ALVAC vCP1452 and recombinant gp160 in newly human immunodeficiency virus type 1-infected patients treated with prolonged highly active antiretroviral therapy. J Virol. 2002 Mar; 76(5):2206-16.
-
HIV envelope proteins differentially utilize CXCR4 and CCR5 coreceptors for induction of apoptosis. Virology. 2001 Jun 20; 285(1):128-37.
-
Major histocompatibility complex genotype is associated with disease progression and virus load levels in a cohort of human immunodeficiency virus type 1-infected Caucasians and African Americans. J Infect Dis. 1998 Dec; 178(6):1799-802.
-
A synthetic peptide from the first conserved region in the envelope protein gp160 is a strong T-cell epitope in HIV-infected chimpanzees and humans. Viral Immunol. 1998; 11(3):147-58.
-
Induction of human immunodeficiency virus-specific T cell responses in rhesus monkeys by synthetic peptides from gp160. AIDS Res Hum Retroviruses. 1993 Mar; 9(3):235-40.
-
HIV envelope protein is recognized as an alloantigen by human DR-specific alloreactive T cells. Hum Immunol. 1992 May; 34(1):31-8.